%0 Journal Article %A Feng Li %A Xiangyang Xue %A Qiang Sun %A Haicheng Tang %A Wenxuan Wang %A Mengwei Gu %A Yanwei Fu %T A machine-learning method based on ocular surface features for COVID-19 screening %D 2020 %R 10.1101/2020.09.03.20184226 %J medRxiv %P 2020.09.03.20184226 %X Background The standard practices for screening patients with COVID-19 are the CT imaging or RT-PCR (real-time polymerase chain reaction) for testing viral nucleic acid, which is expensive and in need of professional equipment and waiting time.Methods Literatures have shown that the COVID-19 patients are usually accompanied by ocular manifestations. We constructed a machine-learning model based on ocular surface features and proposed a new screening method for COVID-19. A retrospective study of analyzing 446 subjects and a prospective study with 128 subjects were conducted with this method. The performance was measured at receiver-operating-characteristic curve (AUC), sensitivity, specificity and accuracy.Results The performance of detecting COVID-19 patients in the retrospective study have achieved an AUC of 0.999 (95% CI, 0.997-1.000), with a sensitivity of 0.982 (95% CI, 0.954-1.000), and a specificity of 0.978 (95% CI, 0.961-0.995). And in the prospective study, our model performance on COVID-19 has achieved an AUC of 0.980 (95% CI, 0.970-0.990), with a sensitivity of 0.770 (95% CI, 0.694-0.846), and a specificity of 0.973(95% CI, 0.957-0.989).Conclusion This deep learning method based on eye-region images demonstrates the high accuracy to distinguish COVID-19 patients. We hope this study can be inspiring and helpful for encouraging more researches on this topic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants were provided with written informed consent at the time of recruitment. And this study was approved by the Ethics Committee of Shanghai public health clinic center of Fudan University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll participants were provided with written informed consent at the time of recruitment. Please contact the first authors, for the data availability. %U https://www.medrxiv.org/content/medrxiv/early/2020/11/02/2020.09.03.20184226.full.pdf